(Q46565107)

23 December 2017

title

Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour (English)

1 reference

23 December 2017

0 references

L Dahan

1

1 reference

23 December 2017

H Husum

2

1 reference

23 December 2017

O Mnie-Filali

3

1 reference

23 December 2017

J Arnt

4

1 reference

23 December 2017

P Hertel

5

1 reference

23 December 2017

N Haddjeri

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

30 May 2008

1 reference

23 December 2017

Journal of Psychopharmacology

published in

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

177-189

1 reference

23 December 2017

The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

(R)-8-OH-DPAT preferentially increases dopamine release in rat medial prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Dopamine agonists in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Involvement of 5-HT1A receptors in the antidepressant-like activity of gepirone in the forced swimming test in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

5-HT1A and beyond: the role of serotonin and its receptors in depression and the antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Prominent burst firing of dopaminergic neurons in the ventral tegmental area during paradoxical sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. III. Activity in models of cognition and negative symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Electrophysiological and pharmacological characteristics of nigral dopaminergic neurons in the conscious, head-restrained rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Serotonin receptors: their key role in drugs to treat schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Receptor mechanisms in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Stress-induced vocalisation in adult animals. A valid model of anxiety?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

Aripiprazole increases dopamine but not noradrenaline and serotonin levels in the mouse prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089586

21 January 2018

Identifiers

DOI

10.1177/0269881108089586

1 reference

23 December 2017

1 reference

23 December 2017